Literature DB >> 16179370

Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury.

Daniel E Cramer1, Daniel J Allendorf, Jarek T Baran, Richard Hansen, Jose Marroquin, Bing Li, Janina Ratajczak, Mariusz Z Ratajczak, Jun Yan.   

Abstract

Myelotoxic injury in the bone marrow (BM) as a consequence of total body irradiation (TBI) or granulocyte colony-stimulating factor (G-CSF) mobilization results in the deposition of iC3b on BM stroma (stroma-iC3b). In the present study, we have examined how stroma-iC3b interacts with hematopoietic progenitor cells (HPCs) and the role of complement (C) and complement receptor 3 (CR3) in BM injury/repair. We demonstrate here that stroma-iC3b tethers HPCs via the inserted (I) domain of HPC complement receptor 3 (CR3, CD11b/CD18, Mac-1). Following irradiation, stroma-iC3b was observed in the presence of purified IgM and normal mouse serum (NMS), but not serum from Rag-2(-/-) mice, implicating a role for antibody (Ab) and the classic pathway of C activation. Furthermore, a novel role for soluble yeast beta-glucan, a ligand for the CR3 lectin-like domain (LLD), in the priming of CR3(+) HPC is suggested. Soluble yeast beta-glucan could enhance the proliferation of tethered HPCs, promote leukocyte recovery following sublethal irradiation, and increase the survival of lethally irradiated animals following allogeneic HPC transplantation in a CR3-dependent manner. Taken together, these observations suggest a novel role for C, CR3, and beta-glucan in the restoration of hematopoiesis following injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179370      PMCID: PMC1895628          DOI: 10.1182/blood-2005-07-2705

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration.

Authors:  D Mastellos; J C Papadimitriou; S Franchini; P A Tsonis; J D Lambris
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

2.  Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.

Authors:  Nai-Kong V Cheung; Shakeel Modak; Andrew Vickers; Benny Knuckles
Journal:  Cancer Immunol Immunother       Date:  2002-09-20       Impact factor: 6.968

3.  The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines.

Authors:  J L Turnbull; M L Patchen; D T Scadden
Journal:  Acta Haematol       Date:  1999       Impact factor: 2.195

4.  Expression of lineage markers by CD34+ hematopoietic stem cells of adult mice.

Authors:  Akaru Ishida; Haiqun Zeng; Makio Ogawa
Journal:  Exp Hematol       Date:  2002-04       Impact factor: 3.084

Review 5.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.

Authors:  Tsvee Lapidot; Isabelle Petit
Journal:  Exp Hematol       Date:  2002-09       Impact factor: 3.084

6.  Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.

Authors:  Hong Lin; Yu-Hong She; Barrie R Cassileth; Frank Sirotnak; Susanna Cunningham Rundles
Journal:  Int Immunopharmacol       Date:  2004-01       Impact factor: 4.932

7.  Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1.

Authors:  Gerjo A Velders; Johannes F M Pruijt; Perry Verzaal; Ronald van Os; Yvette van Kooyk; Carl G Figdor; Evert-Jan F M de Kruijf; Roel Willemze; Willem E Fibbe
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

8.  Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1.

Authors:  Ryan Reca; Dimitrios Mastellos; Marcin Majka; Leah Marquez; Janina Ratajczak; Silvia Franchini; Aleksandra Glodek; Marek Honczarenko; Lynn A Spruce; Anna Janowska-Wieczorek; John D Lambris; Mariusz Z Ratajczak
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

9.  Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow.

Authors:  Janina Ratajczak; Ryan Reca; Magda Kucia; Marcin Majka; Daniel J Allendorf; Jarek T Baran; Anna Janowska-Wieczorek; Rick A Wetsel; Gordon D Ross; Mariusz Z Ratajczak
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

10.  Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.

Authors:  Feng Hong; Richard D Hansen; Jun Yan; Daniel J Allendorf; Jarek T Baran; Gary R Ostroff; Gordon D Ross
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

View more
  15 in total

1.  Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity.

Authors:  Hong Lin; Elisa de Stanchina; Xi Kathy Zhou; Feng Hong; Andrew Seidman; Monica Fornier; Wei-Lie Xiao; Edward J Kennelly; Kathleen Wesa; Barrie R Cassileth; Susanna Cunningham-Rundles
Journal:  Cancer Immunol Immunother       Date:  2010-02-06       Impact factor: 6.968

Review 2.  Effects of glucan on bone marrow.

Authors:  Petr Sima; Luca Vannucci; Vaclav Vetvicka
Journal:  Ann Transl Med       Date:  2014-02

3.  Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer.

Authors:  Bing Li; Yihua Cai; Chunjian Qi; Richard Hansen; Chuanlin Ding; Thomas C Mitchell; Jun Yan
Journal:  Clin Cancer Res       Date:  2010-09-20       Impact factor: 12.531

4.  Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production.

Authors:  Hong Lin; Sandy W Y Cheung; Mirjana Nesin; Barrie R Cassileth; Susanna Cunningham-Rundles
Journal:  Clin Vaccine Immunol       Date:  2006-11-08

5.  Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways.

Authors:  Bing Li; Daniel Cramer; Stephanie Wagner; Richard Hansen; Chelsea King; Shelly Kakar; Chuanlin Ding; Jun Yan
Journal:  Clin Immunol       Date:  2007-06-14       Impact factor: 3.969

6.  Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse.

Authors:  Hong Lin; Elisa De Stanchina; Xi Kathy Zhou; Yuhong She; Danthanh Hoang; Sandy Wy Cheung; Barrie Cassileth; Susanna Cunningham-Rundles
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-14

Review 7.  Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.

Authors:  Jingjing Liu; Lacey Gunn; Richard Hansen; Jun Yan
Journal:  Exp Mol Pathol       Date:  2009-01-21       Impact factor: 3.362

8.  Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and organ injury in rats.

Authors:  A Sandvik; Y Y Wang; H C Morton; A O Aasen; J E Wang; F-E Johansen
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 9.  Pharmacological Modulation of Radiation Damage. Does It Exist a Chance for Other Substances than Hematopoietic Growth Factors and Cytokines?

Authors:  Michal Hofer; Zuzana Hoferová; Martin Falk
Journal:  Int J Mol Sci       Date:  2017-06-28       Impact factor: 5.923

10.  Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes.

Authors:  H M Lee; W Wu; M Wysoczynski; R Liu; E K Zuba-Surma; M Kucia; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.